about
Orthostatic Hypotension: Epidemiology, Prognosis, and TreatmentLate thrombosis after double versus single drug-eluting stent in the treatment of coronary bifurcations: a meta-analysis of randomized and observational StudiesCardiovascular morbidity and mortality related to orthostatic hypotension: a meta-analysis of prospective observational studiesHospital admissions for orthostatic hypotension and syncope in later life: insights from the Malmö Preventive Project.Role and importance of ultrasound lung comets in acute cardiac care.Complete myocardial revascularization confers a larger clinical benefit when performed with state-of-the-art techniques in high-risk patients with multivessel coronary artery disease: A meta-analysis of randomized and observational studies.Ultra-Sensitive Copeptin and Cardiac Troponin in Diagnosing Non-ST-Segment Elevation Acute Coronary Syndromes--The COPACS Study.Right heart-pulmonary circulation unit and cardiac resynchronization therapy.Lung ultrasonography: a practical guide for cardiologists.Non-Vitamin K Antagonist Oral Anticoagulants for Cardioversion in Atrial Fibrillation: An Updated Meta-analysis.Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation.ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure - A network meta-analysis.[Antithrombotic therapy in atrial fibrillation: state of the art and perspectives].Proteomic Profiling for Cardiovascular Biomarker Discovery in Orthostatic Hypotension.Biomarkers of microvascular endothelial dysfunction predict incident dementia: a population-based prospective study.Prognostic value of pulmonary blood volume by first-pass contrast-enhanced CMR in heart failure outpatients: the PROVE-HF study.N-Terminal Prosomatostatin and Risk of Vascular Dementia.Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease.Psychotropic drugs and ventricular repolarisation: The effects on QT interval, T-peak to T-end interval and QT dispersion.Cardiovascular risk after hospitalisation for unexplained syncope and orthostatic hypotension.Athlete's Heart: Diagnostic Challenges and Future PerspectivesCardiovascular biomarkers predict fragility fractures in older adultsHeart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudyPrevalence and Clinical Relevance of Extracardiac Findings in Cardiovascular Magnetic Resonance ImagingInfluence of image reconstruction parameters on cardiovascular risk reclassification by Computed Tomography Coronary Artery Calcium ScoreGrading of aortic stenosis severity: a head-to-head comparison between cardiac magnetic resonance imaging and echocardiographyUltrasound imaging of abdominal sarcoidosis: State of the artPacing therapy in the management of unexplained syncope: a tertiary care centre prospective studyMultislice computed tomography to rule out coronary allograft vasculopathy in heart transplant patientsInflammatory biomarker profiling in classical orthostatic hypotension: Insights from the SYSTEMA cohortScoring atherosclerosis in the search of evidence-based personalized medicineDeterminants of long-term clinical outcomes in patients with angina but without obstructive coronary artery disease: a systematic review and meta-analysisDysregulation of the "inflammatory reflex" with abnormal neurohumoral activation may contribute to proinflammatory activity driving the progression of COPDManagement of hyperuricemia and gout in obese patients undergoing bariatric surgeryPrognostic significance of noncardiac syncope in the general population: A systematic review and meta-analysisAuthors' Reply to Kindermann et al.'s Comment on: "Athlete's Heart: Diagnostic Challenges and Future Perspectives"In complex coronary bifurcations, should a dedicated stent be better than a dedicated approach?Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial FibrillationThe co-predictive value of a cardiovascular score for CV outcomes in diabetic patients with no atrial fibrillationCardiac Magnetic Resonance Evaluation of Pulmonary Transit Time and Blood Volume in Adult Congenital Heart disease
P50
Q26799072-44F9F328-DD60-4E9C-A139-0F148E3F870EQ26861546-7796B6E2-71AA-4707-93EF-57724A61E536Q28080660-4DBD818B-51CB-4209-8A97-E647A9961F20Q33168054-B4FDEFDB-05F7-4FD1-B7C1-C07E17E81C8BQ38255455-D0C095C6-962C-40B8-B8DE-0A91AC6DD6A5Q38407905-2F2695A8-7D12-45AC-93D4-DE894E8442B3Q38408114-041FAFD9-A17D-49A6-9D72-6C34286AB60BQ38749615-433E3C14-1EC4-44D3-B05A-2F73B4288AF7Q39184238-465B3087-C33A-41E5-988C-7BEB464334B4Q39280222-B73BAD31-B9B3-446D-827B-4114DDC073D2Q39709336-C4FC722F-A939-40C8-A969-C1890AB8456BQ39765726-422447FF-C850-4C70-99DC-7E5244942825Q44415808-9D985C8D-6FF4-4760-91EA-0857231C74DDQ47237034-921977EC-3EFB-48C6-8460-A773974E67E0Q48277492-E8AB26F5-1561-42CC-8B1B-24674A96DEFEQ50089619-0F4C0EFE-24A2-4D8A-A580-657EF4EEAF5AQ50273018-6EC3D968-0BAF-4372-AF4E-4E99E9099E03Q51835046-18C64A6E-0542-4441-930F-C38091503310Q53535324-78DD2024-759F-4FE0-B758-07E3B4B5C463Q55033627-D048A60E-FD8B-4614-93B1-74EF797DDD33Q57152063-07EA727C-BE0E-48AF-B18C-C76D53C16C15Q57462905-C6FC97CC-B227-4937-83DC-44A3F5F45A6AQ57626028-16658A0B-FADC-44A4-A6ED-645394781199Q57725621-2A64AD13-33B3-45F5-8AA8-A94FCC63659CQ57725635-DE80CAB9-0843-42B4-A8F9-D50BB8F3A076Q62075644-776D4CAE-3607-44F2-A07D-C8A47A99EAE1Q64039436-742E9BAC-A2FE-4A28-8BAC-BD3AE3E724D0Q64056270-1868AEF7-5ADF-4DED-A26F-9BA3428A18A0Q85599240-7456C762-7679-4D90-83FB-2FB904634A5BQ88176531-AA45B273-D32B-4761-BB4E-BB2333C3C04CQ88363885-8C34BC72-47CB-4B12-B8D3-59444BE2B723Q88454385-D4D8A836-0465-463E-82F7-23CF8801EE40Q89030363-C91BCFBC-B972-4B85-A5F7-E33203D93EC4Q89059375-0361A54A-35EC-4AF7-AAFD-99A2E85BF0B6Q90936696-4E726107-EF29-4FFB-A06F-E87692435362Q90954312-AA199507-5098-4751-A185-4431B2D781F4Q91079663-3A8F49AE-7E26-4AF4-81BF-6AB3DBB6D270Q91143392-D646A921-DC8F-42D0-A4E8-FA09D7E4C3C0Q91799459-FC9DC11A-6BBA-4010-AC81-83DAD2D0A74FQ92154312-306750AA-6B31-461B-AE27-558602258359
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Fabrizio Ricci
@ast
Fabrizio Ricci
@en
Fabrizio Ricci
@es
Fabrizio Ricci
@nl
type
label
Fabrizio Ricci
@ast
Fabrizio Ricci
@en
Fabrizio Ricci
@es
Fabrizio Ricci
@nl
prefLabel
Fabrizio Ricci
@ast
Fabrizio Ricci
@en
Fabrizio Ricci
@es
Fabrizio Ricci
@nl
P106
P1153
51665764100
P31
P496
0000-0002-1401-6623